|
|
|
40
|
06319
|
METHOTREXATE 2.5MG TAB (REM/SBI)
|
METHOTREXATE
|
METHOTREXATE
|
10X10
|
A
|
14.79
|
0.15
|
TABLET
|
32
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0631AD
|
METHOTREXATE 2.5MG TAB (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
100'S
|
A
|
12.72
|
0.13
|
TABLET
|
32
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0631AG
|
ZUVITREX 2.5MG TAB (ZUV) METHOTREXATE
|
METHOTREXATE
|
ZUVITREX
|
100'S
|
A
|
13.32
|
0.1332
|
TAB
|
32
|
BOX
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0631D
|
METHOTREXATE 2.5MG TAB (REM)
|
METHOTREXATE
|
METHOTREXATE
|
100'S
|
A
|
14.79
|
0.1479
|
TAB
|
32
|
BOTT
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0631Y
|
METHOTREXATE 2.5MG TAB (FSB/ATB)
|
METHOTREXATE
|
METHOTREXATE
|
100'S
|
A
|
7.48
|
0.07
|
TABLET
|
32
|
TAB
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2022-09-30
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
2022-03-30
|
|
|
|
40
|
0633V
|
METHACOR 25MG/ML INJ (INP/AHI) METHOTREXATE
|
METHOTREXATE
|
METHACOR
|
2ML VIAL
|
B
|
8.70
|
8.70
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0633X
|
UNITREXATE 25MG/ML INJ (UBI/RXP) METHOTREXATE
|
METHOTREXATE
|
UNITREXATE
|
2ML VIAL
|
B
|
7.07
|
7.07
|
INJECTION
|
0
|
VIAL
|
UBI
|
UNITED BIOTECH (P) LIMITED
|
RXP
|
RX PRO INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0633Z
|
ZUVITREX 25MG/ML INJ (ZUV) METHOTREXATE (B)
|
METHOTREXATE
|
ZUVITREX
|
2ML VIAL
|
B
|
5.11
|
5.1104
|
VIAL
|
5
|
VIAL
|
ZUV
|
ZUVIUS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0634M
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
20ML VIAL
|
BQ
|
46.43
|
46.43
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
06351
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
40ML
|
BQ
|
82.12
|
82.12
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|